Edgewise Therapeutics, Inc.
EWTXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Edgewise Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 17, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Longaeva Partners L.P. | 2026-03-31 | 36,931 | $1.16M | SEC filing |
| Advisory Services Network, LLC | 2026-03-31 | 151 | $4.77K | SEC filing |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 2026-03-31 | 16,870 | $531K | SEC filing |
| NEUBERGER BERMAN GROUP LLC | 2026-03-31 | 168,678 | $5.31M | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 648,393 | $20.4M | SEC filing |
| Persistent Asset Partners Ltd | 2026-03-31 | 10,053 | $317K | SEC filing |
| GUGGENHEIM CAPITAL LLC | 2026-03-31 | 11,524 | $363K | SEC filing |
| KVP Capital Advisors, LP | 2026-03-31 | 133,000 | $4.19M | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 192,434 | $6.06M | SEC filing |
| Granahan Investment Management, LLC | 2026-03-31 | 200,843 | $6.33M | SEC filing |
| MassMutual Private Wealth & Trust, FSB | 2026-03-31 | 294 | $9.26K | SEC filing |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 2026-03-31 | 2,849 | Not shown | SEC filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2026-03-31 | 5,600 | $176K | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 38,084 | $1.2M | SEC filing |
| ADAR1 Capital Management, LLC | 2026-03-31 | 90,599 | $2.85M | SEC filing |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2026-03-31 | 14,739 | $464K | SEC filing |
| ARIZONA STATE RETIREMENT SYSTEM | 2026-03-31 | 14,540 | $458K | SEC filing |
| FOX RUN MANAGEMENT, L.L.C. | 2026-03-31 | 7,976 | $242K | SEC filing |
| Centiva Capital, LP | 2026-03-31 | 539 | $17K | SEC filing |
| AlphaCentric Advisors LLC | 2026-03-31 | 15,615 | $492K | SEC filing |
- Each value is checked against Edgewise Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Edgewise Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Edgewise Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-01-21 · Edris Badreddin: Larger than 56 of the 62 other insider sales of Common Stock on file. SEC filing
- 2025-11-12 · Russell Alan J: Larger than 59 of the 62 other insider sales of Common Stock on file. SEC filing
- 2025-08-26 · Russell Alan J: Larger than 59 of the 62 other insider sales of Common Stock on file. SEC filing
- 2024-12-30 · Russell Alan J: Larger than 59 of the 62 other insider sales of Common Stock on file. SEC filing
- 2024-09-20 · Russell Alan J: Larger than 57 of the 62 other insider sales of Common Stock on file. SEC filing
- 2024-01-23 · Carruthers R Michael: Larger than 58 of the 62 other insider sales of Common Stock on file. SEC filing
- 2023-12-26 · Russell Alan J: Larger than all 62 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-04-03–2025-04-03: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2024-01-23–2024-01-23: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-05 | Donovan Joanne M. · CMO | Common Stock | S — Open market or private sale | −50,000 | 38.57 | SEC filing |
| 2026-05-04 | Donovan Joanne M. · CMO | Common Stock | S — Open market or private sale | −5,230 | 31.29 | SEC filing |
| 2026-04-01 | Donovan Joanne M. · CMO | Common Stock | S — Open market or private sale | −28,662 | 32.31 | SEC filing |
| 2026-03-31 | Donovan Joanne M. · CMO | Common Stock | S — Open market or private sale | −21,338 | 32.12 | SEC filing |
| 2026-03-27 | Donovan Joanne M. · CMO | Common Stock | S — Open market or private sale | −6,735 | 30.98 | SEC filing |
| 2026-03-27 | Donovan Joanne M. · CMO | Common Stock | S — Open market or private sale | −9,623 | 30.98 | SEC filing |
| 2026-01-21 | Edris Badreddin · Director | Common Stock | S — Open market or private sale | −7,605 | 29.44 | SEC filing |
| 2026-01-21 | Edris Badreddin · Director | Common Stock | S — Open market or private sale | −13,690 | 29.44 | SEC filing |
Showing 8 of 18 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-05 | Edris Badreddin · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +8,188 | SEC filing |
| 2026-06-05 | Martin Christopher Nathan · Director | Stock Options (Right to buy) | A — Grant, award, or other acquisition | +16,377 | SEC filing |
| 2026-06-05 | Morris Arlene · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,377 | SEC filing |
| 2026-06-05 | Thompson Peter A. · Director, 10% owner | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,377 | SEC filing |
| 2026-06-05 | Edris Badreddin · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +5,619 | SEC filing |
| 2026-06-05 | Fox Jonathan C · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,377 | SEC filing |
| 2026-06-05 | Brege Laura · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +16,377 | SEC filing |
| 2026-05-05 | Donovan Joanne M. · CMO | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −50,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.